NCT00366444View on ClinicalTrials.gov

Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

201

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2006

Conditions

Pain, Postoperative

Interventions

DRUG

diclofenac potassium (XP21L)

25 mg every 6 hours

DRUG

Placebo

Placebo every 6 hours

Trial Locations (6)

15946

Investigative Site, Altoona

21117

Investigative Site, Owings Mills

21122

Investigative Site, Pasadena

84124

Investigative Site, Salt Lake City

92801

Investigative Site, Anaheim

92869

Investigative Site, Orange

All Listed Sponsors

lead

Xanodyne Pharmaceuticals

INDUSTRY

NCT00366444 - Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery | Biotech Hunter | Biotech Hunter